INDP

NASDAQ

Indaptus Therapeutics Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations

News25/Ratings2

Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy. It engages in developing a pre-clinical pipeline of therapeutic candidates intended to elicit anti-tumor and anti-viral responses, as well as cure diseases. The company's lead candidate is Decoy20 that is in pre-clinical stage to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma. It also develops a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company is headquartered in New York, New York.

News · 26 weeks38+133%

2025-10-262026-04-19

Mix1790d

Insider9(53%)
SEC Filings7(41%)
Other1(6%)

Latest news

25 items

1dSEC
Indaptus Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)
3dINSIDER
SEC Form 3 filed by new insider Lu Qinglai
3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
17dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Indaptus Therapeutics Inc.
SCHEDULE 13G/A - Indaptus Therapeutics, Inc. (0001857044) (Subject)
20dSEC
Indaptus Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)
21dINSIDER
SEC Form 3 filed by new insider Yao Yun
3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
21dINSIDER
SEC Form 3 filed by new insider Sino Lion Ventures Ltd
3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
21dINSIDER
SEC Form 3 filed by new insider Dai Junyi
3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
30dSEC
Indaptus Therapeutics Inc. filed SEC Form 8-K: Changes in Control of Registrant, Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits
8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)
30dINSIDER
SEC Form 4 filed by Lazar David E.
4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
37dSEC
SEC Form 10-K filed by Indaptus Therapeutics Inc.
10-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)
55dINSIDER
SEC Form 4 filed by Director Jabbour Jerome D
4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
55dSEC
Indaptus Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Financial Statements and Exhibits
8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)
55dINSIDER
SEC Form 3 filed by new insider Jabbour Jerome D
3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
56dINSIDER
New insider Mcmurdo Matthew Charles claimed ownership of 25,000 shares (SEC Form 3)
3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
69dINSIDER
SEC Form 4 filed by Co-Chief Executive Officer Meckler Jeffrey A
4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
70dSEC
Indaptus Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)
70dSEC
SEC Form DEFA14A filed by Indaptus Therapeutics Inc.
DEFA14A - Indaptus Therapeutics, Inc. (0001857044) (Filer)
91dINSIDER
Director Ben-Tzvi Avraham was granted 25,000 shares, increasing direct ownership by 25,000% to 25,100 units (SEC Form 4)
4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
91dINSIDER
SEC Form 4 filed by Director Natan David
4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
92dSEC
SEC Form DEF 14A filed by Indaptus Therapeutics Inc.
DEF 14A - Indaptus Therapeutics, Inc. (0001857044) (Filer)
93dSEC
Indaptus Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)
101dINSIDER
New insider Natan David claimed no ownership of stock in the company (SEC Form 3)
3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
105dSEC
Indaptus Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)
105dSEC
SEC Form PRE 14A filed by Indaptus Therapeutics Inc.
PRE 14A - Indaptus Therapeutics, Inc. (0001857044) (Filer)
111dSEC
Indaptus Therapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)